跳至主要内容
临床试验/NCT01446887
NCT01446887已完成2 期

Phase II Study of Prophylactic Anticoagulation for Preventing Deep Vein Thrombosis After Total Hip Arthroplasty

JIANG Qing1 个研究点 分布在 1 个国家开始时间: 2007年1月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
试验地点
1
主要终点
all cause DVT

研究概览

简要总结

Deep vein thrombosis (DVT) remains a life-threatening complication of arthroplasty. It remains controversial for anticoagulation strategies after total hip arthroplasty (THA). A randomized double-blind study was conducted to determine whether prophylactic anticoagulation was efficient reduce DVT after THA. subjects who underwent uncemented THA were assigned to prophylactic anticoagulation group or non- prophylactic anticoagulation group. Patients were followed up 3 months later after surgery. DVT was tested by contrast venography. Investigator also used logistic regression analysis with variable selection for obtaining the prediction model of DVT. DVT after THA was affected by personal (age) and clinical factors (mechanical compression, duration of surgery). THA with short duration of surgery did not require prophylactic anticoagulation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
35 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Primary total hip arthroplasty

排除标准

  • Revision hip replacement, total knee replacement, revision knee replacement, semi-hip replacement and cemented THR were excluded.
  • Coagulation related disease and cancer were excluded either.

结局指标

主要结局

all cause DVT

时间窗: 7 days

deep-vein thrombosis nonfatal pulmonary embolism, or death

次要结局

  • Major DVT(7 days)

研究者

发起方
JIANG Qing
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

JIANG Qing

Director, The Center of Diagnosis and Treatment for Joint Disease

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

研究点 (1)

Loading locations...

相似试验